Caris Life Sciences, Inc. (CAI)
NASDAQ · Healthcare
Caris Life Sciences, Inc. Total Liabilities 2023–2025
Caris Life Sciences, Inc. annual/quarterly total liabilities history from 2024 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Caris Life Sciences, Inc. total liabilities for the quarter ending December 31, 2025 were 548.4M, a 11.69% decrease year-over-year.
- Caris Life Sciences, Inc. total liabilities for 2025 were 548.4M, a 11.69% decrease from 2024.
- Caris Life Sciences, Inc. total liabilities for 2024 were 620.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Caris Life Sciences, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $548 |
| 2024 | $621 |
| Caris Life Sciences, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $548 |
| 2024-12-31 | $621 |
Caris Life Sciences, Inc. Total Liabilities — FAQ
Caris Life Sciences, Inc. (CAI) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CAI's total liabilities history?
The chart and table above show Caris Life Sciences, Inc.'s total liabilities by year and by quarter, including the growth rate.